Search Results - Fabienne Portalès

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
    Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study)

    Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study) by Lilian Schwarz, Déwi Vernerey, Jean‐Baptiste Bachet, Jean‐Jacques Tuech, Fabienne Portales, Pierre Michel, António Sá Cunha

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Cetuximab Plus FOLFIRINOX (ERBIRINOX) as First-Line Treatment for Unresectable Metastatic Colorectal Cancer: A Phase II Trial

    Cetuximab Plus FOLFIRINOX (ERBIRINOX) as First-Line Treatment for Unresectable Metastatic Colorectal Cancer: A Phase II Trial by Eric Assénat, Françoise Desseigne, Simon Thézenas, F. Viret, Laurent Mineur, Andrew Kramar, Emmanuelle Samalin, Fabienne Portales, Frédéric Bibeau, Evelyne Crapez-Lopez, Jean Pierre Bleuse, Marc Ychou

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Safety, efficacy and patient-reported outcomes with trifluridine/tipiracil in pretreated metastatic colorectal cancer: results of the PRECONNECT study

    Safety, efficacy and patient-reported outcomes with trifluridine/tipiracil in pretreated metastatic colorectal cancer: results of the PRECONNECT study by Jean‐Baptiste Bachet, Lucjan Wyrwicz, Timothy Price, Chiara Cremolini, Jean-Marc Phélip, Fabienne Portales, Ahmet Özet, İrfan Çiçin, D Atlan, Martin Becquart, Loïck Vidot, Nadjat Mounedji, Eric Van Cutsem, Julien Taı̈eb, Alfredo Falcone

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    P-272 The international, open-label, multicenter phase 2 LAPACT trial of nab-paclitaxel (nab-P) plus gemcitabine (Gem) for patients with locally advanced pancreatic cancer (LAPC)

    P-272 The international, open-label, multicenter phase 2 LAPACT trial of nab-paclitaxel (nab-P) plus gemcitabine (Gem) for patients with locally advanced pancreatic cancer (LAPC) by Pascal, Hammel, Jill, Lacy, Fabienne, Portales, Alberto, Sobrero, Beatriz, García-Paredes, Edward, Kim, Fernando, Rivera, Luis, Manzano Jose, Eric, Terrebonne, Venu, Bathini, Scot, Dowden, Jamil, Asselah, Jack, Shiansong Li, Thomas, Nydam, Louis, Kayitalire, Philip, Philip

    Published 2016
    Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Dual targeting of HER1/EGFR and HER2 with cetuximab and trastuzumab in patients with metastatic pancreatic cancer after gemcitabine failure: results of the “THERAPY”phase 1-2 trial

    Dual targeting of HER1/EGFR and HER2 with cetuximab and trastuzumab in patients with metastatic pancreatic cancer after gemcitabine failure: results of the “THERAPY”phase 1-2 trial... by Eric Assénat, D. Azria, Caroline Mollévi, Rosine Guimbaud, N. Tubiana-Mathieu, Denis Smith, Jean‐Pierre Delord, Emmanuelle Samalin, Fabienne Portales, Christel Larbouret, Bruno Robert, Frédéric Bibeau, Jean‐Pierre Bleuse, Evelyne Lopez‐Crapez, Marc Ychou, André Pèlegrin

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Stereotactic MR-Guided Radiotherapy for Pancreatic Tumors: Dosimetric Benefit of Adaptation and First Clinical Results in a Prospective Registry Study

    Stereotactic MR-Guided Radiotherapy for Pancreatic Tumors: Dosimetric Benefit of Adaptation and First Clinical Results in a Prospective Registry Study by Morgan Michalet, Karl Bordeau, Marie Cantaloube, Simon Valdenaire, Pierre Debuire, Sebastien Simeon, Fabienne Portalès, Roxana Draghici, Marc Ychou, Eric Assénat, Marie Dupuy, Sophie Gourgou, Pierre‐Emmanuel Colombo, Sébastien Carrère, Régis Souche, N. Aillères, P. Fénoglietto, D. Azria, O. Riou

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy: A multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study).

    Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy: A multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study). by Lilian Schwarz, Jean‐Baptiste Bachet, Aurélia Meurisse, Olivier Bouché, Éric Assenat, Guillaume Piessen, Éric Terrebonne, Pascal Hammel, Nicolas Régenet, Célia Turco, Julien Taı̈eb, Jean‐Yves Mabrut, Olivıer Turrini, Fabienne Portales, François Paye, Louise Barbier, Stéphanie Truant, António Sá Cunha

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    The subgroups of the phase III RECOURSE trial of trifluridine/tipiracil (TAS-102) versus placebo with best supportive care in patients with metastatic colorectal cancer

    The subgroups of the phase III RECOURSE trial of trifluridine/tipiracil (TAS-102) versus placebo with best supportive care in patients with metastatic colorectal cancer by Eric Van Cutsem, R. Mayer, Stéphanie Laurent, Robert Winkler, Cristina Grávalos, Manuel Benavides, Federico Longo-Muñoz, Fabienne Portales, Fortunato Ciardiello, Salvatore Siena, Kensei Yamaguchi, Kei Muro, Tadamichi Denda, Yasushi Tsuji, Lukas Makris, Patrick J. Loehrer, Heinz‐Josef Lenz, Atsushi Ohtsu

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancreatic cancer: An open-label, randomized Phase IIb trial

    Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancreatic cancer: An open-label, randomized Phase IIb trial by Pascal Hammel, Fabienne Portales, Laurent Mineur, Jean‐Philippe Metges, Thierry André, Christelle de la Fouchardière, Christophe Louvet, Farid El Hajbi, Roger Faroux, Rosine Guimbaud, David Tougeron, Olivier Bouché, Thierry Lecomte, Christine Rebischung, Christophe Tournigand, Jérôme Cros, Richard Kay, Adam Hamm, Anu Gupta, Jean‐Baptiste Bachet, Iman El Hariry

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma

    Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma by Eric Van Cutsem, Margaret A. Tempero, Darren Sigal, Do‐Youn Oh, Nicola Fazio, Teresa Macarulla, Erika Hitre, Pascal Hammel, Andrew Hendifar, Susan E. Bates, Chung–Pin Li, Sunil R. Hingorani, Christelle de la Fouchardière, Anup Kasi, Volker Heinemann, Anthony Maraveyas, Nathan Bahary, Laura Layos, Vaibhav Sahai, Lei Zheng, Jill Lacy, Joon Oh Park, Fabienne Portales, Paul E. Oberstein, Wilson Wu, Dimitrios Chondros, Andrea J. Bullock

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Incidence of Venous Thromboembolism in Patients With Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes

    Incidence of Venous Thromboembolism in Patients With Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes by Corinne Frère, Barbara Bournet, Sophie Gourgou, Julien Fraisse, Cindy Canivet, Jean M. Connors, Étienne Buscail, Dominique Farge, Barbara Bournet, Cindy Canivet, Étienne Buscail, Nicolas Carrère, Fabrice Muscari, Bertrand Suc, Rosine Guimbaud, C. Couteau, Marion Deslandres, Pascale Rivera, Anne-Pascale Laurenty, Nadim Farés, Karl Barange, Janick Sèlves, Anne Gomez‐Brouchet, Bertrand Napoléon, B. Pujol, Fabien Fumex, Jérôme Desramé, Christine Lefort, Vincent Lépilliez, Rodica Gincul, Pascal Artru, Léa Clavel, Anne‐Isabelle Lemaistre, Laurent Palazzo, Jérôme Cros, Sarah Tubiana, Nicolas Flori, Pierre Sénesse, Pierre‐Emmanuel Colombo, Emmanuelle Samail-Scalzi, Fabienne Portalès, Sophie Gourgou, Claire Honfo Ga, Carine Plassot, Julien Fraisse, Frédéric Bibeau, Marc Ychou, Pierre Guibert, Christelle de la Fouchardière, Matthieu Sarabi, Patrice Peyrat, Séverine Tabone–Eglinger, Caroline Renard, Guillaume Piessen, Stéphanie Truant, A Saudemont, Guillaume Y. Millet, Florence Renaud, Emmanuelle Leteurtre, Patrick Gelé, Eric Assénat, Jean-Michel Fabre, Régis Souche, Marie Dupuy, Anne-Marie Gorce-Dupuy, José Ramos, J. F. Seitz, Jean Hardwigsen, Emmanuelle Norguet-Monnereau, Philippe Grandval, Muriel Duluc, Dominique Figarella‐Branger, V. Vendrely, Clément Subtil, Eric Terrebonne, Jean-Frédéric Blanc, Étienne Buscail, Jean‐Philippe Merlio, Dominique Farge, Jean-Marc Gornet, Daniela Géromin, Geoffroy Vanbiervliet, Anne-Claire Frin, Delphine Ouvrier, Marie‐Christine Saint‐Paul, Philippe Berthelémy, Chelbabi Fouad, Stéphane Garcia, Nathalie Lesavre, Mohamed Gasmi, Marc Barthet, Vanessa Cottet, Cyrille Delpierre

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Is survival influenced by metastatic site in synchronous metastatic pancreatic adenocarcinoma (PDAC)? A prospective real-world BACAP study

    Is survival influenced by metastatic site in synchronous metastatic pancreatic adenocarcinoma (PDAC)? A prospective real-world BACAP study by Emily Alouani, Cindy Canivet, Barbara Bournet, L. Buscail, J. Selves, Bertrand Napoléon, L. Palazzo, Nicolas Flori, Pierre Guibert, A.-C. Brunac, Charlotte Maulat, F. Muscari, F.-Z. Mokrane, S. Gourgou, Lise Roca, Rosine Guimbaud, Nikoly T. Fares, Barbara Bournet, Cindy Canivet, Étienne Buscail, Nicolas Carrere, Fabrice Muscari, Bertrand Suc, Rosine Guimbaud, C. Couteau, Marion Deslandres, Pascale Rivera, Anne-Pascale Laurenty, Nadim Farés, Karl Barange, Janick Sèlves, Anne Gomez‐Brouchet, Bertrand Napoléon, B. Pujol, Fabien Fumex, Jérôme Desramé, Christine Lefort, Vincent Lépilliez, Rodica Gincul, Pascal Artru, Léa Clavel, Anne‐Isabelle Lemaistre, Laurent Palazzo, Jérôme Cros, Sarah Tubiana, Nicolas Flori, Pierre Sénesse, Pierre‐Emmanuel Colombo, Emmanuelle Samail-Scalzi, Fabienne Portales, Sophie Gourgou, Claire Honfo Ga, Carine Plassot, Julien Fraisse, F. Bibeau, Marc Ychou, Pierre Guibert, Christelle de la Fouchardière, Matthieu Sarabi, Patrice Peyrat, Séverine Tabone–Eglinger, Caroline Renard, Guillaume Piessen, Stéphanie Truant, A Saudemont, Guillaume Y. Millet, Florence Renaud, Emmanuelle Leteurtre, Patrick Gelé, Eric Assenat, Jean-Michel Fabre, Régis Souche, Marie Dupuy, Anne-Marie Gorce-Dupuy, José Ramos, Jean‐François Seitz, Jean Hardwigsen, Emmanuelle Norguet-Monnereau, Philippe Grandval, Muriel Duluc, Dominique Figarella‐Branger, V. Vendrely, C. Subtil, Eric Terrebonne, Jean-Frederic Blanc, Étienne Buscail, Jean‐Philippe Merlio, Dominique Farge Bancel, Jean-Marc Gornet, Daniela Géromin, Geoffroy Vanbiervliet, Anne-Claire Frin, Delphine Ouvrier, Marie‐Christine Saint‐Paul, Philippe Berthelémy, Chelbabi Fouad, Stéphane Garcia, Nathalie Lesavre, Mohamed Gasmi, Marc Barthet

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: